These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 24836726)
1. Current role of neprilysin inhibitors in hypertension and heart failure. von Lueder TG; Atar D; Krum H Pharmacol Ther; 2014 Oct; 144(1):41-9. PubMed ID: 24836726 [TBL] [Abstract][Full Text] [Related]
2. Vasopeptidase inhibition: a new concept in blood pressure management. Burnett JC J Hypertens Suppl; 1999 Feb; 17(1):S37-43. PubMed ID: 10340842 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin II Receptor Blocker Neprilysin Inhibitor (ARNI): New Avenues in Cardiovascular Therapy. Volpe M; Tocci G; Battistoni A; Rubattu S High Blood Press Cardiovasc Prev; 2015 Sep; 22(3):241-6. PubMed ID: 26100410 [TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine activation as a target of modern chronic heart failure pharmacotherapy. Dobrek Ł; Thor P Acta Pol Pharm; 2011; 68(3):307-16. PubMed ID: 21648184 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic Progress and Knowledge Basis on the Natriuretic Peptide System in Heart Failure. Fu S; Chang Z; Luo L; Deng J Curr Top Med Chem; 2019; 19(20):1850-1866. PubMed ID: 31448711 [TBL] [Abstract][Full Text] [Related]
16. ARNi: A Novel Approach to Counteract Cardiovascular Diseases. Volpe M; Rubattu S; Battistoni A Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035359 [TBL] [Abstract][Full Text] [Related]
17. Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides. D'Elia E; Iacovoni A; Vaduganathan M; Lorini FL; Perlini S; Senni M Eur J Heart Fail; 2017 Jun; 19(6):710-717. PubMed ID: 28326642 [TBL] [Abstract][Full Text] [Related]
18. Vasopeptidase inhibition: a novel approach to cardiovascular therapy. Floras JS Can J Cardiol; 2002 Feb; 18(2):177-82. PubMed ID: 11875587 [TBL] [Abstract][Full Text] [Related]
19. Is there a future for direct renin inhibitors? Chaudhary K; Nistala R; Whaley-Connell A Expert Opin Investig Drugs; 2010 May; 19(5):653-61. PubMed ID: 20380486 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic options of Angiotensin Receptor Neprilysin inhibitors (ARNis) in chronic heart failure with reduced ejection fraction: Beyond RAAS and sympathetic nervous system inhibition. Volterrani M; Iellamo F; Senni M; Piepoli MF Int J Cardiol; 2017 Jan; 226():132-135. PubMed ID: 27184730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]